Anna Wald, MD, MPH

/content/dam/www/faculty-photos/W/anna-wald/anna-wald.jpg
Dr. Anna Wald MD, MPH
faculty member

Anna Wald, MD, MPH

Professor, Vaccine and Infectious Disease Division, Fred Hutch

Professor
Vaccine and Infectious Disease Division, Fred Hutch

Member, Pathogen-Associated Malignancies Integrated Research Center (PAM IRC)

Member
Pathogen-Associated Malignancies Integrated Research Center (PAM IRC)

Fax: 206.520.4371
Mail Stop: 358-115

Dr. Anna Wald is a Fred Hutch physician and a clinical virology researcher who also heads the Division of Allergy and Infectious Diseases at the University of Washington. She is an expert on infections in patients whose immune systems have been compromised by cancer treatment or viruses such as HIV. Her research is concentrated on the epidemiology, treatment and prevention of herpesviruses, and the development of new vaccines for a variety of viral pathogens. She is an investigator in clinical trials of the AstraZeneca COVID-19 vaccine and is involved in projects to develop home test kits for self-collection of blood samples for coronavirus antibody studies.

Other Appointments & Affiliations

Physician, Infectious Disease Consulting Service, Fred Hutch

Physician, Infectious Disease Consulting Service
Fred Hutch

Head, Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington School of Medicine

Head, Division of Allergy and Infectious Diseases
Department of Medicine, University of Washington School of Medicine

Professor, Epidemiology; Division of Allergy and Infectious Diseases, Laboratory Medicine and Pathology, University of Washington School of Medicine

Professor, Epidemiology; Division of Allergy and Infectious Diseases, Laboratory Medicine and Pathology
University of Washington School of Medicine

Education

MPH, Epidemiology, University of Washington, 1994

MD, Mount Sinai School of Medicine, 1985

BA, Comparative Religion, Wesleyan University, 1979

Research Interests

Epidemiology, natural history, therapy, and prevention of human herpesvirus infections

Clinical trials of novel vaccines and therapeutics for viral pathogens